TRIAMCINOLONE ACETONIDE SUBSTIPHARM 55 micrograms/dose, suspension for spraying nasal bottle, 20 ml
Active ingredients: Triamcinolone acetonide
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for sprayingbottle, 20 mlnasale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRIAMCINOLONE ACETONIDE SUBSTIPHARM 55 microgrammes/dose, suspension pour pulvérisation nasale
- Pharmaceutical form
- suspension pour pulvérisation
- Route of administration
- nasale
- Presentation description
- 1 flacon pulvérisateur polyéthylène haute densité (PEHD) de 20 mL (soit 120 pulvérisations) avec pompe doseuse avec embout nasal
- Marketing authorisation holder
- SUBSTIPHARM
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 31 Dec 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68808419CIP73029701CIP133400930297018Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACÉTONIDE DE TRIAMCINOLONEsuspension | 55 microgrammes · une dose délivrée | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.